Cargando…

Clinical protocols for (31)P MRS of the brain and their use in evaluating optic pathway gliomas in children

INTRODUCTION: In vivo (31)P Magnetic Resonance Spectroscopy (MRS) measures phosphorus-containing metabolites that play an essential role in many disease processes. An advantage over (1)H MRS is that total choline can be separated into phosphocholine and glycerophosphocholine which have opposite asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Jan, Wilson, Martin, MacPherson, Lesley, Arvanitis, Theodoros N., Davies, Nigel P., Peet, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ireland Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029084/
https://www.ncbi.nlm.nih.gov/pubmed/24331847
http://dx.doi.org/10.1016/j.ejrad.2013.11.009
Descripción
Sumario:INTRODUCTION: In vivo (31)P Magnetic Resonance Spectroscopy (MRS) measures phosphorus-containing metabolites that play an essential role in many disease processes. An advantage over (1)H MRS is that total choline can be separated into phosphocholine and glycerophosphocholine which have opposite associations with tumour grade. We demonstrate (31)P MRS can provide robust metabolic information on an acceptable timescale to yield information of clinical importance. METHODS: All MRI examinations were carried out on a 3T whole body scanner with all (31)P MRS scans conducted using a dual-tuned (1)H/(31)P head coil. Once optimised on phantoms, the protocol was tested in six healthy volunteers (four male and two female, mean age: 25 ± 2.7). (31)P MRS was then implemented on three children with optic pathway gliomas. RESULTS: (31)P MRS on volunteers showed that a number of metabolite ratios varied significantly (p < 0.05 ANOVA) across different structures of the brain, whereas PC/GPC did not. Standard imaging showed the optic pathway gliomas were enhancing on T1-weighted imaging after contrast injection and have high tCho on (1)H MRS, both of which are associated with high grade lesions. (31)P MRS showed the phosphocholine/glycerophosphocholine ratio to be low (<0.6) which suggests low grade tumours in keeping with their clinical behaviour and the histology of most biopsied optic pathway gliomas. CONCLUSION: (31)P MRS can be implemented in the brain as part of a clinical protocol to provide robust measurement of important metabolites, in particular providing a greater understanding of cases where tCho is raised on (1)H MRS.